Home > Healthcare & Medical Devices > Orthopedic Bone Cement and Casting Materials Market
Orthopedic Bone Cement and Casting Materials Market size will expand at an appreciable rate during the forecast timeframe of 2023-2032. The incidence of osteoporosis is rising steadily across the world. 1 in 2 women in the U.S. over the age of 50 is predicted to suffer from osteoporosis-related bone break in her lifetime. Also, the annual number of fractures caused by this chronic condition is projected to touch 3.2 million or 68% by 2040. This has caused a considerable increase in the adoption of bone cement to attach components of a prosthetic joint to weak bones.
Moreover, the healthcare industry is rapidly expanding in developing countries due to the growing presence of skilled medical professionals and introduction of advanced therapeutics. Sports injuries among young athletes are on the rise as well, which will boost the usage of cast materials to fix broken bones. Bone implant procedures are increasing to improve mobility among patients. This factor is expected to bolster the need for bone cement and casting materials, further driving the orthopedic bone cement and casting materials market outlook.
Factors, such as rise in geriatric population and obesity cases have contributed to the global burden of bone-related disorders. Obesity has become a major health issue in countries, such as the United States. As per data by the Trust for America’s Health (TFAH), in 2022, 4 out of 10 adults in the U.S. were obese. This figure can drive the demand for bone casting materials, as obese individuals suffer from low bone density, making them more susceptible to fractures. Furthermore, spinal cord tumors are affecting several children and adolescents, stimulating the use of bone cement in orthopedic surgery, as well as non-invasive procedures like kyphoplasty.
Based on product, orthopedic bone cement and casting materials market is divided into bone cement and casting materials. Casting materials are projected to capture a sizeable market share by 2032 due to the escalating cases of musculoskeletal trauma. According to the WHO, around 1.71 billion people across the world suffer from musculoskeletal diseases, which might augment the use of bone casts to repair broken ribs and treat traumatic injuries.
Based on application, orthopedic bone cement and casting materials industry is segmented into trauma cases, joint arthroplasty, spinal injuries, and sports injuries. The industry size from the joint arthroplasty segment is set to display a strong CAGR through 2032 as the burden of autoimmune diseases, such as rheumatoid arthritis is rising among women. While 14 million people globally suffer from rheumatoid arthritis, women are three times more likely to be diagnosed with this ailment as compared to men. This factor can bolster the preference for total knee arthroplasty among patients to help the joints function properly, thereby spurring the adoption of bone cement and casting materials.
Europe orthopedic bone cement and casting materials market will record substantial gains during the analysis timeframe. The region is noticing a significant growth in its elderly population, which is one of the primary reasons for loss of bone density. According to the WHO, by 2050, people aged 65 years and above are predicted to account for nearly one quarter of the regional population. This scenario will not only increase the number of orthopedic surgeries, but also amplify the regional industry expansion over the coming years.
The key organizations operating in orthopedic bone cement and casting materials market include 3M, Orthofix Holdings, Inc., BSN Medical (Essity), DePuy Synthes (Johnson & Johnson), Smith & Nephew, Stryker Corporation, and Zimmer Biomet, among others. These industry players are launching innovative products and implementing various strategies, such as mergers & acquisitions, to expand their business operations.